ABD-3001

ABD-3001 is an inhibitor of ALDH1. ABD-3001 can be studied in research on refractory/relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome[1].

Product Specifications

CAS Number

[350229-29-7]

UNSPSC

12352211

Target

Aldehyde Dehydrogenase (ALDH)

Related Pathways

Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer

Smiles

O=C(SC)C#CC(C)(C)N(C)C

Molecular Formula

C9H15NOS

Molecular Weight

185.29

References & Citations

[1]Lina Benajiba, et al., Odyssey: A First-in-Human Study of the Aldehyde Dehydrogenase (ALDH) Inhibitor Abd-3001 in Patients with Refractory/Relapsed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) . Blood, 2024 144 (1) : 6001.